Tag: IFPMA

The complex journey of a vaccine-part II
PAHO Foundation annual progress report to IFPMA
Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
IFPMA statement on climate change and health
2015 IFPMA pharma by numbers - Video
IFPMA 2015 pharma by numbers
Supply chain post-approval change
6 ways to getting the supply chain in sync
The exciting journey from flu virus to vaccine
Extension of TRIPS implementation deadline for LDCs
The Exciting Journey from Flu Virus to Vaccine
WTOat20 trade means business (video slideshow)
ICH announces organisational changes as it marks 25 years of successful harmonisation
Global pharmaceutical associations welcome MEDICRIME convention, landmark tool to curb global medicines counterfeiting
Adoption of the sustainable development goals (SDGs)
Translating principles into practice - The pharmaceutical industry's efforts to work towards universal health coverage (UHC)
2015 IFPMA highlight of anti-counterfeit workshop – Senegal
Good pharmacovigilance principles to ensure biotherapeutics safety
1. Counterfeit medicines in legitimate supply chains, A study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
2. Counterfeit medicines in legitimate supply chains, a study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
3. Counterfeit medicines in legitimate supply chains, a study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
4. Counterfeit medicines in legitimate supply chains, a study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
2015 IFPMA highlight of 4th African regulatory conference
IFPMA welcomes seven new members
Rethinking the way we fight bacteria
Phelophepa train of hope
"I am Innovation" (©IFPMA) (Portuguese subtitles)
Release on the Lancet commission on health and climate change report
WHA 68, Item 11.2 Framework of engagement with non-State actors

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Efficacy Epidemics Ethics Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health global health security harmonization Health Partnerships HIV/AIDS IFPMA IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Transparency Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers